ARTICLE | Company News
Pipex submits Coprexa NDA
November 30, 2007 2:41 AM UTC
PP submitted an NDA to FDA for Coprexa oral tetrathiomolybdate to treat initially presenting neurologic Wilson's disease. The anti-copper agent has Orphan Drug designation in the U.S. Wilson's Disease...